| 05 Juin 2014
 
Jordan
 
 On 1 June 2014, the National IHR Focal Point for Jordan reported to WHO  an additional case of Middle East Respiratory Syndrome Coronavirus  (MERS-CoV) in Amman, Jordan.
 
 The case is 26-year-old male health-care worker. He presented with fever  on 23 May 2014. His condition deteriorated as he developed pneumonia  and gastrointestinal symptoms and he was admitted to the hospital on 30  May 2014. A specimen was collected and tested positive for MERS-CoV on  31 May 2014. He is currently in a stable condition. He has no known  comorbidities, but does have a history of contact with a laboratory  confirmed MERS-CoV health-care worker case reported to WHO on 11 May  2014. He has no history of travel and no history of contact with  animals.
 
 Tracing and screening of six family members and 54 health-care workers for MERS-CoV is currently ongoing.
 
 Globally, 681 laboratory-confirmed cases of infection with MERS-CoV  including 204 related deaths have officially been reported to WHO. This  global total includes all of the cases reported in this update, plus 44  laboratory confirmed cases officially reported to WHO by Saudi Arabia  between 19 May and 2 June. WHO is working closely with Saudi Arabia for  additional information on these cases and will provide further updates  as soon as possible.
 
 WHO advice
 
 Based on the current situation and available information, WHO encourages  all Member States to continue their surveillance for severe acute  respiratory infections (SARI) and to carefully review any unusual  patterns.
 
 Infection prevention and control measures are critical to prevent the  possible spread of MERS-CoV in health care facilities. Health-care  facilities that provide for patients suspected or confirmed to be  infected with MERS-CoV infection should take appropriate measures to  decrease the risk of transmission of the virus from an infected patient  to other patients, health-care workers and visitors. Health-care workers  should be educated, trained and refreshed with skills on infection  prevention and control.
 
 It is not always possible to identify patients with MERS-CoV early  because some have mild or unusual symptoms. For this reason, it is  important that health-care workers apply standard precautions  consistently with all patients – regardless of their diagnosis – in all  work practices all the time.
 
 Droplet precautions should be added to the standard precautions when  providing care to all patients with symptoms of acute respiratory  infection. Contact precautions and eye protection should be added when  caring for probable or confirmed cases of MERS-CoV infection. Airborne  precautions should be applied when performing aerosol generating  procedures.
 
 Patients should be managed as potentially infected when the clinical and  epidemiological clues strongly suggest MERS-CoV, even if an initial  test on a nasopharyngeal swab is negative. Repeat testing should be done  when the initial testing is negative, preferably on specimens from the  lower respiratory tract.
 
 Health-care providers are advised to maintain vigilance. Recent  travellers returning from the Middle East who develop SARI should be  tested for MERS-CoV as advised in the current surveillance  recommendations. All Member States are reminded to promptly assess and  notify WHO of any new case of infection with MERS-CoV, along with  information about potential exposures that may have resulted in  infection and a description of the clinical course. Investigation into  the source of exposure should promptly be initiated to identify the mode  of exposure, so that further transmission of the virus can be  prevented.
 
 People at high risk of severe disease due to MERS-CoV should avoid close  contact with animals when visiting farms or barn areas where the virus  is known to be potentially circulating. For the general public, when  visiting a farm or a barn, general hygiene measures, such as regular  hand washing before and after touching animals, avoiding contact with  sick animals, and following food hygiene practices, should be adhered  to.
 
 WHO does not advise special screening at points of entry with regard to  this event nor does it currently recommend the application of any travel  or trade restrictions.